A lightspeed approach to pandemic drug development

被引:10
|
作者
Anderson, Annaliesa S. [1 ]
机构
[1] Pfizer Inc, Worldwide Res Dev & Med, Pearl River, NY 10965 USA
关键词
D O I
10.1038/s41591-022-01945-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pfizer had successes during COVID-19 by streamlining decisions and running several steps in parallel, a lightspeed approach that can be applied to other diseases.
引用
收藏
页码:1538 / 1538
页数:1
相关论文
共 50 条
  • [21] Pandemic Brings Major Changes to FDA and Drug Development in 2020
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2020, 33 (12) : 10 - 12
  • [22] Pandemic brings major changes to fda and drug development in 2020
    Wechsler, Jill
    Pharmaceutical Technology, 2020, 44 (12) : 14 - 15
  • [23] Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development
    Milligan, P. A.
    Brown, M. J.
    Marchant, B.
    Martin, S. W.
    van der Graaf, P. H.
    Benson, N.
    Nucci, G.
    Nichols, D. J.
    Boyd, R. A.
    Mandema, J. W.
    Krishnaswami, S.
    Zwillich, S.
    Gruben, D.
    Anziano, R. J.
    Stock, T. C.
    Lalonde, R. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (06) : 502 - 514
  • [24] A Human Approach to Drug Development: Opportunities and Limitations
    Coleman, Robert A.
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2010, 38 : 21 - 25
  • [25] Flexibility in the FDA approach to orphan drug development
    Hunter, Nina L.
    Rao, Gayatri R.
    Sherman, Rachel E.
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (11) : 737 - 738
  • [26] Clinical trials in drug development: a minimalistic approach
    Verweij, Jaap
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 332 - 337
  • [27] Flexibility in the FDA approach to orphan drug development
    Nina L. Hunter
    Gayatri R. Rao
    Rachel E. Sherman
    Nature Reviews Drug Discovery, 2017, 16 : 737 - 738
  • [28] CLINICAL IMPLICATIONS OF THE ETHOPHARMACOLOGICAL APPROACH TO DRUG DEVELOPMENT
    DIXON, AK
    PSYCHOPHARMACOLOGY, 1990, 101 : S15 - S15
  • [29] A forecasting approach to accelerate drug development - Discussion
    Seldrup, J
    STATISTICS IN MEDICINE, 1998, 17 (15-16) : 1741 - 1743
  • [30] CONCEPT OF PHARMACOSOMA - NEW APPROACH TO DRUG DEVELOPMENT
    RAIKHMAN, LM
    MOSHKOVSKY, YS
    PIRUZYAN, LA
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1978, 12 (04): : 18 - 22